Lv52
1130 积分 2021-05-26 加入
德谷胰岛素利拉鲁肽注射液治疗2型糖尿病患者的药物经济学研究系统评价
6天前
已完结
糖尿病患者体重管理专家共识（2024版）
19天前
已完结
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis
20天前
已完结
Glucagon -like Peptide 1 Receptor Agonist Use and the Effect on Diabetic Retinopathy: An Uncertain Relationship
20天前
已完结
Adherence to glucagon‐like peptide‐1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry study
22天前
已完结
2型糖尿病患者GLP-1类药物真实世界用药模式研究
26天前
已完结
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
1个月前
已完结
Clinical Efficacy of Polyethylene Glycol Loxenatide in the Treatment of Obese or Overweight Patients with Type 2 Diabetes Mellitus
1个月前
已完结
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
2个月前
已完结
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
2个月前
已完结
皖公网安备34019202002308
